A detailed history of Lakeside Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lakeside Advisors, Inc. holds 4,092 shares of BMY stock, worth $234,594. This represents 0.14% of its overall portfolio holdings.

Number of Shares
4,092
Holding current value
$234,594
% of portfolio
0.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$39.66 - $51.75 $162,288 - $211,761
4,092 New
4,092 $211,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lakeside Advisors, Inc. Portfolio

Follow Lakeside Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lakeside Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lakeside Advisors, Inc. with notifications on news.